Organ-on-a-chip and microphysiological systems
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- MILTENYI BIOTEC GMBH
German biotech company providing cell isolation, processing, and GMP manufacturing technology for immunotherapy and advanced cell therapies.
“EUROoC training network for organ-on-a-chip technology, indicating expansion into in-vitro disease modelling platforms.”
DE11 projects - NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN
Biomedical research institute combining organ-on-a-chip engineering, iPSC disease modelling, and biosensor development for drug testing and regenerative medicine.
“Coordinated EUROoC (training network for organ-on-a-chip technology), contributed human-on-the-chip technology in RESHAPE, and developed fluorescence-emitting electrodes for toxicity assessment in TOX-Free.”
PrimaryDE9 projects - BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
Global pharmaceutical company providing industrial drug development expertise and PhD training placements in cardiovascular safety, organ-on-a-chip, and neuroinflammation research.
“EUROoC was a dedicated training network for advancing organ-on-a-chip technology, covering disease modelling and toxicity screening using iPSC-derived tissues.”
PrimaryDE7 projects